Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients

Ali A Haydar1, Adrian Covic, Helen Colhoun

  • 1Renal and Transplantation Unit, Guy's Hospital, London, UK.

Kidney International
|April 17, 2004
PubMed

Insights

Pulse wave velocity (PWV) strongly correlates with coronary artery calcium (CAC) scores in patients with end-stage renal disease (ESRD). This finding highlights PWV as a valuable indicator of arterial stiffness and calcification in this high-risk population.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Radiology

Background:

  • End-stage renal disease (ESRD) patients face elevated cardiovascular risks.
  • Arterial pathologies like atherosclerosis and arteriosclerosis, including medial arterial calcification, contribute to vascular stiffness in ESRD.
  • Understanding the link between arterial stiffness and coronary calcification is crucial for managing cardiovascular complications.

Purpose of the Study:

  • To investigate the relationship between pulse wave velocity (PWV), a measure of arterial stiffness, and coronary artery calcium (CAC) extent.
  • To assess if PWV can serve as a surrogate marker for coronary calcification in ESRD patients.

Main Methods:

  • A study involving 55 ESRD patients (38 male, 17 female) over 2 years.
  • Measurements included electron beam computerized tomography (EBCT) for CAC scoring and PWV assessment.
  • Data were analyzed for correlations between PWV and CAC, adjusting for age, dialysis duration, and C-reactive protein (CRP).

Main Results:

  • The mean age of participants was 56.4 years, with a mean dialysis duration of 65.4 months.
  • A strong positive correlation was observed between PWV and total CAC score (P=0.0001), even after adjustments.
  • Significant differences in CAC scores were noted across different PWV tertiles (P=0.0001).

Conclusions:

  • Pulse wave velocity (PWV) is significantly associated with the extent of coronary artery calcification (CAC) measured by EBCT in chronic kidney disease patients.
  • PWV emerges as a reliable indicator of arterial calcification burden in ESRD.
  • These findings underscore the utility of PWV in assessing cardiovascular risk in ESRD patients.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...